SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (1275)5/28/1999 10:31:00 AM
From: Doug Bean  Read Replies (1) of 1837
 
Vestor :
A friend just spoke with DRMDs IR and says cenestin to be priced only 2% less than Premarin.
This should help avoid a price war.
Interest in Cenestin is still very high and they are running full blast on it.
Does not see any reason it won't be a big hit.

Says the real by win that will come from the new drug is that other large drug manufacturers will see the very advanced "time release" formulation of this new drug and that they will earn more business from this state of the art delivery system.
Feels several of them will need this service and come to them.
CRDoug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext